HER2-IN-7 is a potent HER2 inhibitor with potential for investigating ErbB-related diseases, particularly HER2-associated cancers, by modulating ErbB family signaling pathways involved in proliferation, invasion, metastasis, angiogenesis, and tumor cell survival.